Search research articles
Contact Us
Filters
Showing results (431-440 of 522) with videos related to
Page
of 53
Sort By:
Mbio
|
May 19, 2021
Genotypic and Phenotypic Diversity among Human Isolates of Akkermansia muciniphila
Bradford Becken, Lauren Davey, Dustin R Middleton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 12, 2012
Phase I clinical and pharmacokinetic evaluation of the vascular-disrupting agent OXi4503 in patients with advanced solid tumors
Dan M Patterson, Martin Zweifel, Mark R Middleton, et al.
Science Translational Medicine
|
July 16, 2010
Quinone oxidoreductase-2-mediated prodrug cancer therapy
Mark R Middleton, Richard Knox, Emma Cattell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 24, 2015
Randomized phase II study evaluating veliparib (ABT-888) with temozolomide in patients with metastatic melanoma
M R Middleton, P Friedlander, O Hamid, et al.
BMC Cancer
|
July 24, 2021
A Phase 2a cohort expansion study to assess the safety, tolerability, and preliminary efficacy of CXD101 in patients with advanced solid-organ cancer expressing HR23B or lymphoma
Stephen W Booth, Toby A Eyre, John Whittaker, et al.
Oncotarget
|
October 27, 2015
IGF-1R inhibition induces schedule-dependent sensitization of human melanoma to temozolomide
Roger Ramcharan, Tamara Aleksic, Wilfride Petnga Kamdoum, et al.
Plos One
|
September 15, 2016
Targeted Next-Generation Sequencing of Plasma DNA from Cancer Patients: Factors Influencing Consistency with Tumour DNA and Prospective Investigation of Its Utility for Diagnosis
Pamela J Kaisaki, Anthony Cutts, Niko Popitsch, et al.
British Journal of Cancer
|
February 14, 2018
A first-in-human phase I study to determine the maximum tolerated dose of the oral Src/ABL inhibitor AZD0424
Victoria K Woodcock, Sally Clive, Richard H Wilson, et al.
British Journal of Cancer
|
April 16, 2009
O(6)-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatrib
A J Watson, M R Middleton, G McGown, et al.
Radiology
|
January 16, 2019
Focused Ultrasound Hyperthermia for Targeted Drug Release from Thermosensitive Liposomes: Results from a Phase I Trial
Michael D Gray, Paul C Lyon, Christophoros Mannaris, et al.
Page
of 53
Search research articles
Search
Showing results (431-440 of 522) with videos related to
Sort By:
Page
of 53
Mbio
|
May 19, 2021
Genotypic and Phenotypic Diversity among Human Isolates of Akkermansia muciniphila
Bradford Becken, Lauren Davey, Dustin R Middleton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 12, 2012
Phase I clinical and pharmacokinetic evaluation of the vascular-disrupting agent OXi4503 in patients with advanced solid tumors
Dan M Patterson, Martin Zweifel, Mark R Middleton, et al.
Science Translational Medicine
|
July 16, 2010
Quinone oxidoreductase-2-mediated prodrug cancer therapy
Mark R Middleton, Richard Knox, Emma Cattell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 24, 2015
Randomized phase II study evaluating veliparib (ABT-888) with temozolomide in patients with metastatic melanoma
M R Middleton, P Friedlander, O Hamid, et al.
BMC Cancer
|
July 24, 2021
A Phase 2a cohort expansion study to assess the safety, tolerability, and preliminary efficacy of CXD101 in patients with advanced solid-organ cancer expressing HR23B or lymphoma
Stephen W Booth, Toby A Eyre, John Whittaker, et al.
Oncotarget
|
October 27, 2015
IGF-1R inhibition induces schedule-dependent sensitization of human melanoma to temozolomide
Roger Ramcharan, Tamara Aleksic, Wilfride Petnga Kamdoum, et al.
Plos One
|
September 15, 2016
Targeted Next-Generation Sequencing of Plasma DNA from Cancer Patients: Factors Influencing Consistency with Tumour DNA and Prospective Investigation of Its Utility for Diagnosis
Pamela J Kaisaki, Anthony Cutts, Niko Popitsch, et al.
British Journal of Cancer
|
February 14, 2018
A first-in-human phase I study to determine the maximum tolerated dose of the oral Src/ABL inhibitor AZD0424
Victoria K Woodcock, Sally Clive, Richard H Wilson, et al.
British Journal of Cancer
|
April 16, 2009
O(6)-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatrib
A J Watson, M R Middleton, G McGown, et al.
Radiology
|
January 16, 2019
Focused Ultrasound Hyperthermia for Targeted Drug Release from Thermosensitive Liposomes: Results from a Phase I Trial
Michael D Gray, Paul C Lyon, Christophoros Mannaris, et al.
Page
of 53